Barclay Alec 4
4 · T2 Biosystems, Inc. · Filed Mar 30, 2022
Insider Transaction Report
Form 4
Barclay Alec
SVP, Operations
Transactions
- Exercise/Conversion
Common Stock
2022-03-14+21,666→ 180,421 total - Tax Payment
Common Stock
2022-03-14$0.36/sh−11,428$4,160→ 168,993 total - Exercise/Conversion
Restricted Stock Units
2022-03-14−21,666→ 21,667 total→ Common Stock (21,666 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]11,428 shares of common stock were automatically withheld at vesting to cover required tax withholding.
- [F3]On March 14, 2020 the reporting person was granted 65,000 that vest in three equal annual installments commencing on March 14, 2021.